Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 20% ± 3% | |
epithelial cell | 5 studies | 27% ± 14% | |
natural killer cell | 4 studies | 19% ± 4% | |
neuron | 3 studies | 22% ± 5% | |
retinal cone cell | 3 studies | 31% ± 13% | |
fibroblast | 3 studies | 19% ± 3% | |
regulatory T cell | 3 studies | 17% ± 1% | |
macrophage | 3 studies | 18% ± 1% | |
GABAergic neuron | 3 studies | 36% ± 7% | |
glutamatergic neuron | 3 studies | 45% ± 11% | |
oligodendrocyte | 3 studies | 21% ± 1% | |
plasmacytoid dendritic cell | 3 studies | 18% ± 2% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 16% ± 0% | |
astrocyte | 3 studies | 23% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 32% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2029.02 | 2642 / 2642 | 100% | 16.81 | 705 / 705 |
breast | 100% | 1685.05 | 459 / 459 | 100% | 14.76 | 1118 / 1118 |
esophagus | 100% | 1462.97 | 1445 / 1445 | 100% | 10.75 | 183 / 183 |
liver | 100% | 972.79 | 226 / 226 | 100% | 7.84 | 406 / 406 |
ovary | 100% | 1589.32 | 180 / 180 | 100% | 8.68 | 430 / 430 |
prostate | 100% | 1448.00 | 245 / 245 | 100% | 12.00 | 502 / 502 |
uterus | 100% | 1550.52 | 170 / 170 | 100% | 12.09 | 459 / 459 |
thymus | 100% | 1781.82 | 653 / 653 | 100% | 13.41 | 604 / 605 |
stomach | 100% | 1273.81 | 359 / 359 | 100% | 10.05 | 285 / 286 |
intestine | 100% | 1586.65 | 966 / 966 | 100% | 9.96 | 525 / 527 |
bladder | 100% | 1568.48 | 21 / 21 | 100% | 10.12 | 502 / 504 |
adrenal gland | 100% | 2088.45 | 258 / 258 | 100% | 11.11 | 229 / 230 |
lung | 99% | 1480.56 | 575 / 578 | 100% | 9.73 | 1155 / 1155 |
kidney | 100% | 1695.97 | 89 / 89 | 99% | 10.85 | 896 / 901 |
pancreas | 99% | 934.56 | 325 / 328 | 100% | 9.43 | 178 / 178 |
skin | 100% | 1803.66 | 1808 / 1809 | 97% | 11.10 | 456 / 472 |
adipose | 100% | 1724.76 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 13.47 | 29 / 29 |
spleen | 100% | 1805.59 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.73 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.14 | 1 / 1 |
blood vessel | 100% | 1514.04 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1390.81 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 1067.13 | 833 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 6.15 | 72 / 80 |
peripheral blood | 72% | 1059.46 | 673 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001525 | Biological process | angiogenesis |
GO_0001570 | Biological process | vasculogenesis |
GO_0001938 | Biological process | positive regulation of endothelial cell proliferation |
GO_0007155 | Biological process | cell adhesion |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0005576 | Cellular component | extracellular region |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
GO_0003676 | Molecular function | nucleic acid binding |
Gene name | AGGF1 |
Protein name | Angiogenic factor with G patch and FHA domains 1, isoform CRA_a (cDNA FLJ75192) Angiogenic factor with G-patch and FHA domains 1 Angiogenic factor with G patch and FHA domains 1 AGGF1 protein Angiogenic factor with G patch and FHA domains 1 (Angiogenic factor VG5Q) (hVG5Q) (G patch domain-containing protein 7) (Vasculogenesis gene on 5q protein) |
Synonyms | GPATCH7 hCG_37487 GPATC7 VG5Q |
Description | FUNCTION: Promotes angiogenesis and the proliferation of endothelial cells. Able to bind to endothelial cells and promote cell proliferation, suggesting that it may act in an autocrine fashion. . |
Accessions | A8K029 Q8N302 H0Y8F8 A0JLT8 ENST00000502408.1 Q6PIK7 ENST00000506806.1 [Q8N302-3] ENST00000312916.12 [Q8N302-1] |